Fibrocell Science, Inc.·4

Mar 2, 4:32 PM ET

Fibrocell Science, Inc. 4

4 · Fibrocell Science, Inc. · Filed Mar 2, 2016

Insider Transaction Report

Form 4
Period: 2016-03-01
Maslowski John Michael
VP, Scientific Affairs
Transactions
  • Award

    Option to Purchase Common Stock

    2016-03-01+100,000100,000 total
    Exercise: $2.27Exp: 2026-03-01Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]The options set forth in this table vest as follows: 25,000 vesting on March 1, 2017 and 75,000 vesting in 12 equal quarterly installments beginning on June 1, 2017 and ending on March 1, 2020, subject to the grantee's continued service.
  • [F2]The options were issued in connection with the reporting person's employment service to the Company.

Documents

1 file
  • 4
    wf-form4_145695434261473.xmlPrimary

    FORM 4